Showing results 3 to 4 of 4
< previous
Title | Author(s) | Issue Date | |
---|---|---|---|
Coagulation factors in citrated plasma predict for benefit from bevacizumab (B) in patients with advanced pancreatic cancer (APC): Results from CALGB 80303 (Alliance) Proceeding/Conference:Journal of Clinical Oncology | 2015 | ||
Prognostic and predictive blood-based biomarkers of overall survival (OS) in patients (pts) with advanced colorectal cancer (CRC) treated with cetuximab (C): Results from CALGB 80203 (Alliance) Proceeding/Conference:Journal of Clinical Oncology | 2014 |